Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism

Activation of metabotropic glutamate receptor subtype 5 (mGlu(5)) represents a novel strategy for therapeutic intervention into multiple central nervous system disorders, including schizophrenia. Recently, a number of positive allosteric modulators (PAMs) of mGlu(5) were discovered to exhibit in viv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bridges, Thomas M., Rook, Jerri M., Noetzel, Meredith J., Morrison, Ryan D., Zhou, Ya, Gogliotti, Rocco D., Vinson, Paige N., Xiang, Zixiu, Jones, Carrie K., Niswender, Colleen M., Lindsley, Craig W., Stauffer, Shaun R., Conn, P. Jeffrey, Daniels, J. Scott
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Pharmacology and Experimental Therapeutics 2013
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3876804/
https://ncbi.nlm.nih.gov/pubmed/23821185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.113.052084
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados